Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Partovian C, Li SX, Xu X, Lin H, Strait KM, Hwa J, Krumholz HM
Thankfully, Sesame unlocks lower cost and convenient access for everyone involved
Furthermore, of the 201 variants with nucleotide substitutions, 200 were missense variants instead of nonsense variants, meaning that the mutations cause a change in amino acid rather than a premature termination of translation
